Skip to main content
HR 19 116th Congress House Health Administrative law and regulatory procedures Administrative remedies Advisory bodies Appropriations Biological and life sciences Business records Cancer Chemistry Child health Civil actions and liability Competition and antitrust Congressional oversight Consumer affairs Corporate finance and management Cosmetics and personal care Department of Health and Human Services Digestive and metabolic diseases Drug safety, medical device, and laboratory regulation Drug therapy

Lower Costs, More Cures Act of 2019

Introduced: December 9, 2019 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 19, 2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Dec 10, 2019
Referred to the Subcommittee on Health.
Dec 9, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 9, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Lower Costs, More Cures Act of 2019

This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs.

The bill generally

  • limits payment amounts for drugs and biologics under Medicare medical services,
  • reduces cost-sharing under the Medicare prescription drug benefit,
  • modifies certain authorities and requirements under the Medicaid Drug Rebate Program,
  • revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and
  • establishes several reporting requirements for drug manufacturers with respect to drug prices.
What's happening now December 19, 2019

Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

 Related & companion bills 14
  • HR 3408 Related bill Shop Rx Act of 2019
  • HR 3415 Related bill Real-Time Beneficiary Drug Cost Bill
  • HR 5444 Related bill Lower Insulin Costs Now Act
  • S 801 Related bill A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and…
  • S 1999 Related bill Improving Low Income Access to Prescription Drugs Act of 2019
  • S 2051 Related bill Strengthening Average Sales Price Reporting Act of 2019
  • S 3013 Related bill Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
  • HR 5882 Related bill GENE Therapy Payment Act
  • S 3942 Related bill Securing America’s Medical Supply Chain and Advancing the Production of Life Saving Medicines Act
  • HR 6155 Related bill To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition…
  • HR 7877 Related bill Lowering Drug Costs for Seniors Act of 2020
  • HR 7898 Related bill To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and …
  • S 3129 Related bill Lower Costs, More Cures Act of 2019
  • HR 4955 Related bill Protecting Access to Safe and Effective Medicines Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Cosponsors 125
All 125 Republican 84
Brooks, Mo
· Aug 18, 2020
 R
Wittman, Robert J.
Virginia · Jan 29, 2020
 R
Crawford, Eric A. "Rick"
Arkansas · Jan 8, 2020
 R
DesJarlais, Scott
Tennessee · Dec 18, 2019
 R
Gooden, Lance
Texas · Dec 18, 2019
 R
Timmons, William R.
South Carolina · Dec 18, 2019
 R
Bergman, Jack
Michigan · Dec 13, 2019
 R
Fulcher, Russ
Idaho · Dec 13, 2019
Hice, Jody
· Dec 13, 2019
 R
Simpson, Michael K.
Idaho · Dec 13, 2019
 R
Burchett, Tim
Tennessee · Dec 11, 2019
 R
Carter, John R.
Texas · Dec 11, 2019
 R
Perry, Scott
Pennsylvania · Dec 11, 2019
 R
Scott, Austin
Georgia · Dec 11, 2019
THORNBERRY, WILLIAM
· Dec 11, 2019
Zeldin, Lee
· Dec 11, 2019
 R
Bacon, Don
Nebraska · Dec 10, 2019
 R
Barr, Andy
Kentucky · Dec 10, 2019
 R
Bost, Mike
Illinois · Dec 10, 2019
Byrne, Bradley
· Dec 10, 2019
 R
Dunn, Neal P.
Florida · Dec 10, 2019
Granger, Kay
· Dec 10, 2019
 R
Harris, Andy
Maryland · Dec 10, 2019
KING, PETER
· Dec 10, 2019
 R
Meuser, Daniel
Pennsylvania · Dec 10, 2019
 R
Moolenaar, John R.
Michigan · Dec 10, 2019
 R
Rogers, Harold
Kentucky · Dec 10, 2019
 R
Smucker, Lloyd
Pennsylvania · Dec 10, 2019
 R
Webster, Daniel
Florida · Dec 10, 2019
 R
Womack, Steve
Arkansas · Dec 10, 2019
Abraham, Ralph
· Dec 9, 2019
 R
Aderholt, Robert B.
Alabama · Dec 9, 2019
 R
Allen, Rick W.
Georgia · Dec 9, 2019
 R
Amodei, Mark E.
Nevada · Dec 9, 2019
 R
Arrington, Jodey C.
Texas · Dec 9, 2019
 R
Babin, Brian
Texas · Dec 9, 2019
 R
Baird, James R.
Indiana · Dec 9, 2019
 R
Balderson, Troy
Ohio · Dec 9, 2019
 R
Banks, Jim
Indiana · Dec 9, 2019
 R
Bilirakis, Gus M.
Florida · Dec 9, 2019
BRADY, KEVIN
· Dec 9, 2019
Brooks, Susan
· Dec 9, 2019
 R
Buchanan, Vern
Florida · Dec 9, 2019
 R
Budd, Ted
North Carolina · Dec 9, 2019
 R
Carter, Earl L. "Buddy"
Georgia · Dec 9, 2019
CHABOT, STEVE
· Dec 9, 2019
Cheney, Liz
· Dec 9, 2019
 R
Cole, Tom
Oklahoma · Dec 9, 2019
Collins, Doug
· Dec 9, 2019
 R
Comer, James
Kentucky · Dec 9, 2019
Page 1 of 3 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 19: Lower Costs, More Cures Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-19/
MLA
"H.R. 19: Lower Costs, More Cures Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-19/.
Bluebook (legal)
H.R. 19, 116th Cong. (2026), https://openamerica.io/bill/116-HR-19/.
Markdown link
[H.R. 19: Lower Costs, More Cures Act of 2019](https://openamerica.io/bill/116-HR-19/)
Report a problem